Press Release

28 December 2018

Change in Number of Shares and Votes in Immunicum AB (publ) After Completed Directed Issue

Immunicum AB (publ) (the "Company" or "Immunicum") has, as previously announced, implemented a directed issue to a number of institutional and private investors. The newly implemented share issue has entailed a change in number of shares and votes in the Company.

Through the directed issue, the number of shares and votes in Immunicum have increased by 20,915,588, which has increased the share capital by SEK 1,045,779.40. As of December 28 2018, the total share capital in Immunicum amounts to SEK 3,593,705.95 and the total number of shares and votes amount to 71,874,119.

This information is such information that Immunicum AB (publ) is obliged to make public pursuant to the Swedish Financial Instruments Trading Act (Sw. lagen (1991:980) om handel med finansiella instrument). The information was submitted for publication, through the agency of the contact persons set out below, on December 28 2018, at 8:30 CET.

For more information, please contact:

Carlos de Sousa, CEO, Immunicum
Telephone: +46 (0) 31 41 50 52
E-mail: info@immunicum.com  

Michaela Gertz, CFO, Immunicum
Telephone: +46 70 926 17 75
E-mail: ir@immunicum.com